This lack of transparency can be boiled down to a couple reasons that are all intertwined. First, what’s holding everything back is the taboo against cannabis (“marijuana”) that continues to exist in our society. We still hear amazingly exaggerated horror stories of what marijuana can do to us. The Reefer Madness that started back in the 1930s hasn’t gone away. This recent video of Gary Johnson faking a heart attack because of a ludicrous claim against marijuana is just one example.
I woke up seriously looking forward to my morning CBD oil fix … I mean, tonic. Truth be told, I’m an anxious person. Although I do a lot to try and calm my nerves, sometimes anxiety gets the best of me. But regardless of emotional or physical stress (I’m training for a marathon and running quite a bit!) I experienced this week, I felt a lot more in control after drinking my CBD oil tonics.  After work, I met up with a friend and felt like I could fully focus on our conversation without distractions. Could it be the CBD?

I have tried NatureCBD and believe in the product. I particularly noticed alleviation in joint pain and reduction in stress – although stress reduction may have been supported by pain reduction. However, since I live in Canada and it is expensive to ship, I have been using CBD from a licensed medical marijuana facility. The effect is not as powerful as from NatureCBD. I had not really considered the bioavailability issue; perhaps that is the reason for the weaker effect. Or possibly it could be the other herbs added, or the synergistic effect. In any case, I am going to bite the bullet (at least my visa card will) and go back to NatureCBD.
2.)   Another great conclusion concerning the benefits of CBD hemp oil and Alzheimer’s, “In conclusion, we have found that prepotentially relievement with CBD prevented the expression of proteins potentially involved in tau phosphorylation and Aβ production in GMSCs. Therefore, we suggested that GMSCs preconditioned with CBD possess a molecular profile that might be more beneficial for the potentially relievement of AD.”
In the United States, non-FDA approved CBD products are classified as Schedule I drugs under the Controlled Substances Act.[62] This means that production, distribution, and possession of non-FDA approved CBD products is illegal under federal law. In addition, in 2016 the Drug Enforcement Administration added "marijuana extracts" to the list of Schedule I drugs, which it defined as "an extract containing one or more cannabinoids that has been derived from any plant of the genus Cannabis, other than the separated resin (whether crude or purified) obtained from the plant."[63] Previously, CBD had simply been considered "marijuana", which is a Schedule I drug.[62][64]
×